investor.cyaninc.com
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
investor.cyclacel.com
Overview | Cyclacel Pharmaceuticals, Inc.
Skip to main navigation. Research and Development Pipeline. CYC116 Aurora Kinase and VEGFR2 Inhibitor. Cell Cycle in Cancer. Drug Discovery and Development Approach. Corporate Presentations and Events. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc.'s financial performance into perspective. Fourth Quarter and Full Year 2017 Financial Results. 30th Annual ROTH Conference.
investor.cyilimited.com
China Yuchai International Limited (“CYI”) - Investor Relations - Investors Home
Q2 2015 China Yuchai International Limited Earnings Conference Call. 160;at 8:00 pm ET. Q2 2015 China Yuchai International Limited Earnings Conference Call. Tuesday, August 11, 2015 . 8:00 pm ET . Through Tuesday, August 11, 2015 . Click here for webcast. Click here to add this event to your calendar. CYI has also invested in HL Global Enterprises Limited ( HLGE ) which is listed on the main board of the Singapore Exchange. Currently, CYI holds 48.9% shareholding interest in HLGE. The core businesses of...
investor.cyxone.com
Cyxone » Investor relations
Cyxone är ett resurssnålt bolag. Cyxone är ett resurssnålt bolag fokuserat på att utveckla läkemedelskandidaten T20K mot Multipel Skleros (MS). T20K har passerat forskningsstadiet vilket kortar ner tiden till värdehöjande händelser som t.ex. kliniska studier. De egenskaper T20K visat i cell- och djurstudier har potential att utveckla substansen till en genombrottsprodukt för att behandla MS-patienter i olika sjukdomsstadier. VD Kjell Stenberg presenterar Cyxone på Stora Aktiedagen i Stockholm.
investor.cz
WEST BROKERS a.s.
Vážení zákazníci, dovolujeme si Vás seznámit se změnami, ke kterým došlo u obchodníka s cennými papíry WEST BROKERS a.s., IČ: 64832341, se sídlem Slovanská 100, 326 00 Plzeň, zapsaný v OR vedeném Krajským soudem v Plzni, oddíl B, vložka 1004. V souladu s ustanovením 18 odst. 2, zákona č. 256/2004 Sb., o podnikání na kapitálovém trhu společnost WEST BROKERS a.s. od účinnosti rozhodnutí valné hromady, tj. od 31.5.2008 pouze vydává zákaznický majetek a vypořádává své pohledáv...
investor.daily.co.uk
Daily Investors
Annualised revenue per service per customer starts. At 259 for domain registration services up to 350k for. A PCI DSS Hosting cluster (‘Payment Card Industry Data. Now provides a broad range of infrastructure and cloud based services. To individuals, small to medium enterprises ( SMEs ) and larger corporates. To become the one-stop supplier of reliable, scalable, high performance. And resilient infrastructure based hosting products. OUR BUSINESS STATISTICS and INFORMATION.
investor.daktronics.com
Investor Relations | Daktronics, Inc.
Skip to main navigation. Out of Home Advertising. Digit and Price Displays. ITS Dynamic Message Signs. Annual Reports and Proxy. Annual Reports and Proxy. News and Event Alerts. Daktronics designs, manufactures, sells and services dynamic visual communication systems for customers worldwide. Daktronics is a public corporation whose stock is traded on the Nasdaq national market under the symbol DAKT. Mar 28, 2018. Daktronics Unveils Major Innovation For Traffic Applications. Mar 27, 2018. Mar 02, 2018.
investor.darden.com
Darden Restaurants, Inc. - Investors - Investor Relations
Doing Business With Darden. Energy and Water Conservation. The Darden family of restaurants features some of the most recognizable and successful brands in full-service dining. Through subsidiaries, we own and operate more than 1,600 restaurants, employ 165,000 people and serve 380 million guests a year. Be financially successful through great people consistently delivering outstanding food, drinks and service in an inviting atmosphere, making every guest loyal! March 22, 2018. February 26, 2018. Darden ...
investor.deere.com
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
investor.delphi.com
Delphi - Login
We have emailed you instructions. We can help you reset your password using your email address linked to your account. Your full suite of IR tools in one unique platform. This site is protected by Two-Factor Authentication. Please download Google Authenticator from the App Store for iOS or the Play Store for Android. For other devices, download an authenticator app from your device store. Secret key (excluding spaces):. Enter the PIN to verify your identity. Need help? Remember this computer for 30.
investor.dendreon.com
Dendreon Corporation - News and Information
Medical Affairs Web site. Dendreon Corporation is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients. View all ». Feb 10, 2015. Dendreon Announces Expiration of Bid Deadline In Connection With Agreement to Sell Substantially All Assets to Valeant. Feb 5, 2015. Jan 29, 2015. Stipulation of Settlement of Certain Shareholder Litigation.
